Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PD-L1 PET Imaging in Patients With an Inoperable Melanoma With Brain Metastasis and Eligible for Treatment With Nivolumab.

NCT03520634 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT03520634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03520634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PD-L1 PET Imaging in Patients With an Inoperable Melanoma With Brain Metastasis and Eligible for Treatment With Nivolumab.
Lead sponsor
University Medical Center Groningen
Phase
Not applicable
Overall status
Completed
Start date
May 22, 2017
Completion date
April 12, 2021
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma